← Eichor
Study identifier: NCT06499246 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Parathyroid Allotransplant for Severe Refractory Hypoparathyroidism

Condition: Hypoparathyroidism Postprocedural  ·  Sponsor: Karen Devon

PhaseNA
Planned participants5
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

Hypoparathyroidism following thyroid surgery presents significant challenges, often leading to debilitating symptoms and reduced quality of life despite conventional treatment. Having now reported the first successful case of a deceased donor fresh tissue parathyroid allotransplant with immunosuppression in a transplant-naive recipient, the purpose of this study is to further assess the safety and efficacy of this procedure in patients with severe intractable post-surgical hypoparathyroidism.

This description comes directly from the study's public registry record.

Talk to the study team

Karen Devon, MD, MSc, FRCSC, FACS  ·  416-323-6400  ·  karen.devon@wchospital.ca

Esther Lee, BScN  ·  416-340-4800  ·  esther.lee@uhn.ca

Always discuss trial participation with your own doctor first.

Locations (1)

University Health NetworkToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06499246